Ahn et al [39] also reported poor prognostic impact (short OS, short RFS and high relapse rate) of DNMT3A R882 mutations in Korean patients with CN-AML after hematopoietic cell transplantation. Here, DNMT3A is linked to acute myeloid leukemia.